Education
About Us
Working with TipRanks
Follow Us
Alvotech (ALVO)
:ALVO
ALVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.35 - $13.70
Previous CloseN/A
Volume41.59K
Average Volume (3M)290.88K
Market Cap
$2.60B
Enterprise Value$4.11B
Total Cash (Recent Filing)$38.54M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)25.6
Beta0.81
Next Earnings
Aug 13, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding301,805,660
10 Day Avg. Volume275,399
30 Day Avg. Volume290,878
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue7.01
Enterprise Value/Gross Profit11.57
Enterprise Value/Ebitda29.58
Forecast
1Y Price Target
$21.00Price Target Upside136.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Alvotech News
ALVO FAQ
What was Alvotech’s price range in the past 12 months?
Alvotech lowest stock price was $7.35 and its highest was $13.70 in the past 12 months.
What is Alvotech’s market cap?
Alvotech’s market cap is $2.60B.
When is Alvotech’s upcoming earnings report date?
Alvotech’s upcoming earnings report date is Aug 13, 2025 which is in 5 days.
How were Alvotech’s earnings last quarter?
Alvotech released its earnings results on May 07, 2025. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of -$0.113 by $0.463.
Is Alvotech overvalued?
According to Wall Street analysts Alvotech’s price is currently Undervalued.
Does Alvotech pay dividends?
Alvotech does not currently pay dividends.
What is Alvotech’s EPS estimate?
Alvotech’s EPS estimate is -0.05.
How many shares outstanding does Alvotech have?
Alvotech has 301,805,660 shares outstanding.
What happened to Alvotech’s price movement after its last earnings report?
Alvotech reported an EPS of $0.35 in its last earnings report, beating expectations of -$0.113. Following the earnings report the stock price went up 18.136%.
Which hedge fund is a major shareholder of Alvotech?
Currently, no hedge funds are holding shares in ALVO
Alvotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.00 (136.75% Upside)
$21.00 (136.75% Upside)
Blogger Sentiment
Bullish
ALVO Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 12.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 45.3%
Last 30 Days ▲ 45.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.92%
12-Months-Change
Fundamentals
Return on Equity
128.44%
Trailing 12-Months
Asset Growth
17.43%
Trailing 12-Months
Company Description
Alvotech
Alvotech (ALVO) is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. The company operates within the healthcare sector and focuses on providing affordable, high-quality, and accessible biologic treatments to patients worldwide. Alvotech's core products include biosimilar versions of complex biologics used in the treatment of various diseases such as autoimmune disorders, oncology, and other chronic conditions.
ALVO Company Deck
ALVO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong financial performance with raised revenue guidance and successful product launches, despite some challenges like strong price competition and potential tariff impacts.View all ALVO earnings summariesALVO Stock 12 Month Forecast
Average Price Target
$21.00
▲(136.75% Upside)
Technical Analysis
Dynavax
―
Perrigo Company
―
Supernus Pharmaceuticals
―
HUTCHMED
―
Amneal Pharmaceuticals
―
Ownership Overview
―
Insiders
1.60% Mutual Funds
0.02% Other Institutional Investors
98.01% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---